Uncoupler therapy for NAFLD: is flushing a possible harbinger of a safety concern? - Authors' reply

Lancet Gastroenterol Hepatol. 2024 Feb;9(2):105-106. doi: 10.1016/S2468-1253(23)00446-6.

Authors

Mazen Noureddin¹, Diane Jorkasky², Shaharyar Khan³, Arun J Sanyal⁴

Affiliations

¹ Houston Research Institute, Houston Methodist Hospital, Houston, TX 77079, USA. Electronic address: noureddinmd@houstonresearchinstitute.com.
² Philadelphia, PA, USA.
³ Rivus Pharmaceuticals, Charlottesville, VA, USA.
⁴ Stravitz-Sanyal Institute of Liver Disease and Metabolic Health, Department of Internal Medicine, VCU School of Medicine, Richmond, VA, USA.

PMID: 38215776
DOI: 10.1016/S2468-1253(23)00446-6

No abstract available

Publication types

Letter

MeSH terms

Humans
Non-alcoholic Fatty Liver Disease*